🇺🇸 FDA
Pipeline program

Fezolinetant

2693-CL-0310

Phase 3 small_molecule completed

Quick answer

Fezolinetant for Hot Flashes is a Phase 3 program (small_molecule) at Astellas Pharma Inc with 1 ClinicalTrials.gov record(s).

Program details

Company
Astellas Pharma Inc
Indication
Hot Flashes
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials